Tate & Lyle | TATE - Cash And Equivalent

Stock Price
389.20
Daily Change
-5.80 -1.47%
Monthly
7.40%
Yearly
-40.67%
Q1 Forecast
369.11

Tate & Lyle reported GBP475M in Cash and Equivalent for its fiscal semester ending in June of 2023.





Cash And Equivalent Change Date
Agrana Beteiligungs EUR 88.9M 29.44M Sep/2025
Anglo-eastern Plants USD 244.7M 62.79M Jun/2025
Associated British Foods GBP 758M 1.36B Dec/2024
Austevoll Seafood NOK 4.69B 228M Sep/2025
Beiersdorf EUR 1.17B 40M Jun/2025
British American Tobacco GBP 5.93B 1.28B Jun/2024
Danone EUR 1.62B 144M Jun/2025
Diageo GBP 2.2B 544M Jun/2025
Givaudan CHF 603M 3M Jun/2024
Glanbia EUR 417M 116.1M Jan/2025
Imperial Brands GBP 1.85B 1.26B Dec/2022
International Flavors Fragrances USD 621M 195M Sep/2025
L'Oréal EUR 4.82B 769.6M Jun/2025
Nestle CHF 4.65B 904M Jun/2025
Nomad Foods EUR 193.6M 73M Sep/2025
Ontex EUR 96.7M 39.8M Jun/2025
Pernod Ricard EUR 1.94B 748M Dec/2024
Premier Foods GBP 64.4M 10.1M Dec/2023
Primary Health Properties ZAR 11.5M 8M Jun/2025
Reckitt Benckiser GBP 880M 106M Dec/2024
Tate & Lyle GBP 475M 41M Jun/2023
Unilever EUR 4.34B 1.79B Jun/2025